Clinical trial
Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab (Nucala): a French SNDS Database Study
NCT04550780 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nation-wide Health Resource Consumption and Costs Associated With Mepolizumab (Nucala): a French SNDS Database Study
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 3, 2021
- Completion date
- July 31, 2023
- Enrollment
- 7,938 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.